isomethyleugenol has been researched along with Lymphoma, Large B-Cell, Diffuse in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 16 (80.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, L; Pan, H; Shi, W; Yan, Q | 1 |
| Arrowsmith, CH; Barsyte-Lovejoy, D; Brown, PJ; Frye, SV; Gao, C; Hahn, KM; Huang, XP; James, LI; Jiang, A; Jin, J; Konze, KD; Kuznetsova, E; Li, F; Liu, F; Ma, A; Macnevin, CJ; Norris, JL; Parton, T; Pattenden, SG; Roth, BL; Rougie, M; Vedadi, M; Wang, GG | 1 |
| Cerchietti, L; Leonard, JP | 1 |
| Asmar, F; de Nully Brown, P; Grønbæk, K; Hother, C; Kulosman, G; Møller, MB; Nielsen, HM; Pedersen, A; Ralfkiaer, E; Ralfkiaer, U; Treppendahl, MB | 1 |
| Albrecht, BK; Arora, S; Audia, JE; Balasubramanian, S; Bradley, WD; Bryant, BM; Busby, J; Campbell, R; Cantone, N; Cook, AS; Cummings, RT; Dakin, LA; Daniels, DL; Garapaty-Rao, S; Gehling, VS; Harmange, JC; Hatton, C; Iyer, P; Méndez, J; Nasveschuk, CG; Normant, E; Trojer, P; Vaswani, RG; Williamson, KE; Yuan, CC; Zhao, F | 1 |
| Chen, YH; Gao, J; Licht, JD; Parimi, V; Popovic, R; Winter, JN; Wolniak, K; Zhou, Z | 1 |
| Bastard, C; Bertrand, P; Bohers, E; Cornic, M; Dubois, S; Jardin, F; Lanic, H; Maingonnat, C; Marchand, V; Mareschal, S; Penther, D; Picquenot, JM; Ruminy, P; Tilly, H; Veresezan, EL; Viailly, PJ | 1 |
| Abbas, S; Aguiar, RC; Bouamar, H; Dahia, PL; DeBerardinis, RJ; Deutsch, A; Escobedo, Y; Gao, X; Hinck, A; Kim, SW; Lin, AP; Mohan, S; Neumeister, P; Ortega, M; Qin, Y; Rakheja, D; Schulz, E; Sill, H; Sudderth, J; Ulz, P; Varadarajan, P; Weintraub, ST | 1 |
| Kim, EK; Oh, EJ; Yang, WI; Yoon, SO | 1 |
| Atadja, P; Dillon, MP; Fang, D; Feng, L; Fu, X; Gabriel, T; Gao, Z; Gu, J; Guo, H; Huang, Y; Jiang, X; Li, L; Lingel, A; Liu, X; Liu, Y; Mi, Y; Oyang, C; Qi, W; Shultz, MD; Sun, Y; Wang, L; Wang, Y; Yu, Z; Zeng, J; Zhang, C; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, Q; Zhao, K; Zhao, M | 1 |
| Wang, S; Yang, CY | 1 |
| Licht, JD; Martinez-Garcia, E | 1 |
| Aparicio, SA; Arrowsmith, CH; Berg, T; Boyle, M; Cheng, SW; Chu, J; Gascoyne, RD; Humphries, RK; Marquez, VE; Marra, MA; Meissner, B; Moradian, A; Morin, GB; Morin, RD; Mungall, AJ; Schapira, M; Yap, DB | 1 |
| Bhagat, G; Chadburn, A; Chan, J; Chiarenza, A; Dalla-Favera, R; Elliot, O; Fabbri, G; Gaidano, G; Grunn, A; Ma, J; Messina, M; Mullighan, CG; Pasqualucci, L; Rabadan, R; Rossi, D; Trifonov, V; Wells, VA | 1 |
| Elemento, O; Jiang, Y; Melnick, AM; Soong, TD; Wang, L | 1 |
| Brandt, M; Creasy, CL; Della Pietra, A; Dhanak, D; Diaz, E; Duquenne, C; Ganji, G; Graves, AP; Korenchuk, S; Kruger, RG; LaFrance, LV; Liu, Y; McCabe, MT; McHugh, CF; Mellinger, M; Miller, WH; Ott, HM; Thompson, C; Tian, X; Tummino, PJ; Van Aller, GS; Verma, SK | 1 |
| Ardayfio, O; Atadja, P; Chan, H; Chen, Z; Chuai, S; Fan, H; Fang, J; Feng, G; Gu, J; Li, E; Li, G; Li, L; Li, M; Lin, Y; Liu, X; Lu, CX; Mi, Y; Qi, W; Teng, L; Yan, X; Yang, T; Yu, Z; Zeng, J; Zhang, JH; Zhang, M; Zhang, R; Zhao, K; Zhou, T | 1 |
| Ambrosetti, A; Arrigoni, G; Capello, D; Dell'Oro, S; Ferrarese, F; Ferreri, AJ; Foppoli, M; Gaidano, G; Iuzzolino, P; Orvieto, E; Pasini, F; Ponzoni, M; Reni, M; Rossi, D | 1 |
| Fitzgibbon, J; Joel, S; Last, K; Lister, TA; Maharaj, L; Perry, J; Strauss, S | 1 |
| Krüger, FW; Osswald, H; Schelten, E; Walker, G | 1 |
1 review(s) available for isomethyleugenol and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Targeting the epigenome and other new strategies in diffuse large B-cell lymphoma: beyond R-CHOP.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Enzyme Inhibitors; Epigenesis, Genetic; Epigenomics; Histones; Humans; Lymphoma, Large B-Cell, Diffuse; Methylation; Prednisone; Rituximab; Vincristine | 2013 |
19 other study(ies) available for isomethyleugenol and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
METTL3 enhances the effect of YTHDF1 on NEDD1 mRNA stability by m6A modification in diffuse large B-cell lymphoma cells.
Topics: Animals; CD8-Positive T-Lymphocytes; Hedgehog Proteins; Humans; Lymphoma, Large B-Cell, Diffuse; Methylation; Methyltransferases; Mice; Microtubule-Associated Proteins; RNA-Binding Proteins; Signal Transduction | 2023 |
An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1.
Topics: Administration, Oral; Animals; Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Histones; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methylation; Mice; Polycomb Repressive Complex 2 | 2013 |
Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another "double hit" lymphoma with very poor outcome?
Topics: Aged; Antigens, CD19; B-Lymphocytes; Cell Line, Tumor; Codon, Nonsense; Female; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Male; Methylation; MicroRNAs; Middle Aged; Mutation, Missense; Prognosis; Promoter Regions, Genetic; Survival Rate; Tumor Suppressor Protein p53 | 2014 |
EZH2 inhibitor efficacy in non-Hodgkin's lymphoma does not require suppression of H3K27 monomethylation.
Topics: Amino Acid Sequence; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Enzyme Inhibitors; Histones; Humans; Kinetics; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methylation; Mice; Mice, Nude; Mutation; Peptides; Polycomb Repressive Complex 2; Small Molecule Libraries; Transplantation, Heterologous | 2014 |
Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutation.
Topics: Cell Line, Tumor; Codon; Computational Biology; Datasets as Topic; Disease Progression; DNA Mutational Analysis; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histones; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Methylation; Mutation; Polycomb Repressive Complex 2 | 2015 |
Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: implications for targeted EZH2 inhibitor therapy?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Male; Methylation; Middle Aged; Polycomb Repressive Complex 2; Young Adult | 2015 |
D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2.
Topics: Alcohol Oxidoreductases; Blotting, Western; Cell Line, Tumor; Dioxygenases; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; HEK293 Cells; Histones; Humans; Hydroxylation; Hypoxia-Inducible Factor 1, alpha Subunit; Isocitrate Dehydrogenase; Ketoglutaric Acids; Lymphoma, Large B-Cell, Diffuse; Methylation; Real-Time Polymerase Chain Reaction | 2015 |
Activation of the polycomb repressive complex pathway in the bone marrow resident cells of diffuse large B-cell lymphoma patients.
Topics: Adult; Aged; Biopsy; Bone Marrow; Bone Marrow Cells; Cell Nucleus; Disease-Free Survival; Enhancer of Zeste Homolog 2 Protein; Female; Histones; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methylation; Middle Aged; Neoplasm Proteins; Polycomb Repressive Complex 2; Prognosis; Proto-Oncogene Proteins c-myc; Signal Transduction; Transcription Factors; Tumor Microenvironment | 2016 |
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Crystallography, X-Ray; Dogs; Female; Haplorhini; Histones; Humans; Lymphoma, Large B-Cell, Diffuse; Lysine; Male; Methylation; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Docking Simulation; Polycomb Repressive Complex 2; Rats; Sulfones; Triazoles | 2017 |
Allosteric Inactivation of Polycomb Repressive Complex 2 (PRC2) by Inhibiting Its Adapter Protein: Embryonic Ectodomain Development (EED).
Topics: Allosteric Regulation; Animals; Antineoplastic Agents; Drug Discovery; Enhancer of Zeste Homolog 2 Protein; Histones; Humans; Lymphoma, Large B-Cell, Diffuse; Methylation; Mice, Inbred BALB C; Mice, Nude; Models, Molecular; Polycomb Repressive Complex 2 | 2017 |
Deregulation of H3K27 methylation in cancer.
Topics: DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Germinal Center; Histones; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lysine; Methylation; Mutation; Polycomb Repressive Complex 2; Transcription Factors | 2010 |
Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation.
Topics: Biopsy; Catalysis; Cell Line, Tumor; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Histone-Lysine N-Methyltransferase; Histones; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Methylation; Models, Molecular; Mutation, Missense; Polycomb Repressive Complex 2; Substrate Specificity; Transcription Factors | 2011 |
Analysis of the coding genome of diffuse large B-cell lymphoma.
Topics: Chromatin; Diploidy; DNA Mutational Analysis; Gene Dosage; Gene Expression Regulation, Leukemic; Genome, Human; Germinal Center; Humans; Lymphoma, Large B-Cell, Diffuse; Methylation; Neoplasm Recurrence, Local; Point Mutation; Polymorphism, Single Nucleotide; T-Lymphocytes | 2011 |
Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma.
Topics: B-Lymphocytes; Cell Differentiation; Cell Line, Tumor; Chromatin Immunoprecipitation; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Genes, Regulator; Genome, Human; Histones; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Methylation; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Sequence Analysis, DNA; Somatic Hypermutation, Immunoglobulin | 2012 |
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Gene Silencing; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Indoles; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Methylation; Mice; Mutation; Neoplasm Transplantation; Polycomb Repressive Complex 2; Pyridones; Repressor Proteins; Transcriptional Activation; Transplantation, Heterologous | 2012 |
Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p16; Down-Regulation; Embryo, Mammalian; Enhancer of Zeste Homolog 2 Protein; Fibroblasts; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Histone-Lysine N-Methyltransferase; Histones; Lymphoma, Large B-Cell, Diffuse; Methylation; Mice; Mutation; Phenotype; Polycomb Repressive Complex 2; Small Molecule Libraries; Tumor Stem Cell Assay; Up-Regulation | 2012 |
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas.
Topics: Adult; Aged; Antineoplastic Agents; Central Nervous System Neoplasms; CpG Islands; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Membrane Transport Proteins; Methotrexate; Methylation; Middle Aged; Predictive Value of Tests; Prevalence; Reduced Folate Carrier Protein; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA | 2004 |
The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours.
Topics: Apoptosis; Chronic Disease; Flow Cytometry; Glutathione; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Methylation; Organoselenium Compounds; Tumor Cells, Cultured | 2006 |
[The organotropy of alkylating activity of dimethylnitrosamine (DMNA) and nitrosomethyl urea (NMH) in vivo].
Topics: Alkylating Agents; Animals; Body Weight; Carbon Isotopes; Female; Formates; Guanine; Hepatectomy; Injections, Intravenous; Kidney; Liver; Lymphoma, Large B-Cell, Diffuse; Male; Methanol; Methylation; Mice; Muscles; Neoplasm Transplantation; Neoplasms, Experimental; Nitrosamines; Nitroso Compounds; Nitrosourea Compounds; Rats; RNA; RNA, Neoplasm; Salmonidae; Sarcoma, Experimental; Urea | 1970 |